How many insider trades does FilingIQ track for FOLD?

FilingIQ tracks 1,392 Form 4 insider transactions for FOLD (AMICUS THERAPEUTICS, INC.), covering filings from Mar 3, 2014 onwards. 113 of those were filed in the last 90 days.

Are FOLD insiders net buyers or net sellers?

Across the full Form 4 history for FOLD, 48 transactions (3%) were open-market purchases and 368 (26%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does FOLD insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is FOLD in?

AMICUS THERAPEUTICS, INC. (FOLD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $4.50B.

FOLD insider trading

NasdaqGM Healthcare

AMICUS THERAPEUTICS, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

1,392

Last 90 days

113

Buys / sells

3% / 26%

Market cap

$4.50B

About AMICUS THERAPEUTICS, INC.

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally. The company's commercial product and product candidates consist of Galafold, an orally administered monotherapy for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant; Pombiliti + Opfolda, a novel two-component treatment program for adults living with late-onset Pompe disease; and DMX-200, a small molecule inhibitor of the chemokine receptor 2 that is in a pivotal Phase 3 study for the treatment of focal segmental glomerulosclerosis (FSGS) kidney disease. It has collaboration and license agreement with GlaxoSmithKline to develop and commercialize Galafold; and Dimerix Limited for the commercialization of DMX-200 for the treatment of FSGS and other indications. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.

Company website: amicusrx.com

FOLD insider activity at a glance

FilingIQ has scored 1,392 insider transactions for FOLD since Mar 3, 2014. The most recent filing in our index is dated Apr 27, 2026.

Across the full history, 48 open-market purchases and 368 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on FOLD insider trades is 57.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live FOLD trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding FOLD

PERCEPTIVE ADVISORS LLC

$175.15M · 6.2% of AUM

STEMPOINT CAPITAL LP

$14.83M · 4.4% of AUM

Frequently asked

How many insider trades does FilingIQ track for FOLD?: FilingIQ tracks 1,392 Form 4 insider transactions for FOLD (AMICUS THERAPEUTICS, INC.), covering filings from Mar 3, 2014 onwards. 113 of those were filed in the last 90 days.
Are FOLD insiders net buyers or net sellers?: Across the full Form 4 history for FOLD, 48 transactions (3%) were open-market purchases and 368 (26%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does FOLD insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is FOLD in?: AMICUS THERAPEUTICS, INC. (FOLD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $4.50B.

Methodology & sources

Every FOLD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.